Naproxen Sodium
- Product NDC
- 70518-2863
- 11-digit product format
- 705182863
- Labeler code
- 70518
- Product ID
- 70518-2863_dfe98d6e-f5d1-161b-e053-2995a90a1257
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA212199
- Marketing category
- ANDA
- Marketing start
- 2020-08-27
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 550 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2863 | NAPROXEN SODIUM TABLET [REMEDYREPACK INC.] | 9 | Legacy NDC | 20240921_3882db3d-acb9-4eb8-896f-55697a2a955c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2863-0 | 70518286300 | 30 TABLET in 1 BOTTLE, PLASTIC (70518-2863-0) | 30 tablet | 2020-08-27 | 0000-00-00 | No | No | Current |
| 70518-2863-1 | 70518286301 | 30 TABLET in 1 BOTTLE, PLASTIC (70518-2863-1) | 30 tablet | 2022-05-24 | 0000-00-00 | No | No | Current |